JMJD4 (Q9H9V9) variants and mutations

JMJD4 (also known as Q9H9V9) is a human protein-coding gene encoding a 2-oxoglutarate and iron-dependent oxygenase protein. Its annotated function is catalyzes the 2-oxoglutarate and iron-dependent C4-lysyl hydroxylation of ETF1 at 'Lys-63' thereby promoting the translational termination efficiency of ETF1. It is annotated at the cytoplasm. This analysis covers 934 JMJD4 variants and mutations. Of these, 99% have computational variant effect predictions. Disease context includes osteoarthritis, hand, Varicose veins, and Abnormality of the skeletal system. Example JMJD4 variants include D2A, D2G, and D2N.

Variant analysis overview

Variant and mutation evidence

Clinical, disease, and population context

Protein structure and variant hotspots

Data sources

Evidence in this analysis draws on EBI Proteins Variation, UniProt, gnomAD v4, EuropePMC, 3D Hotspot Analysis, Interaction Network Analysis, AlphaFold DB, gnomAD constraint, Open Targets, MaveDB, LitVar.

Notable JMJD4 variants

Examples include D2A, D2G, D2N, D2V, D2Y, R3C, R3G, R3L. Listed records include available protein-change notation, database identifiers, clinical classifications, computational predictions, population evidence, experimental measurements, and disease context.